RISK FACTORS, TREATMENT ORGANIZATION AND QUALITY INDICATORS FOR CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN PRIMARY CARE SETTINGS: DUTCH EXPERIENCE

Abstract


Introduction. Chronic obstructive pulmonary disease (COPD), usually in advanced stages, is associated with high mortality, being the third leading cause of death worldwide. In the Netherlands, care delivery to patients with COPD has become a focus of the regional medical community, since the COPD death rates in this country are higher than the European Union average. However, between 2011 and 2021, the number of people with COPD (under follow-u by general practitioners) decreased. The experience of this country is interesting, as a large set of measures to improve the situation has been developed and implemented in this region. The purpose of the study was to analyze the experience of the Netherlands in organizing medical care for COPD in primary care settings. Material and methods. The search for scientific literature sources was carried out using the PubMed database and Google system. The search time horizon equaled to 5 years. Results. In the Netherlands, in the system of care delivery to patients with COPD, primary care settings are heavily burdened. The article summarizes approaches to identify COPD risk factors, summarizes current clinical recommendations as of December 2022, and highlights findings of the study on medical digital platforms with the potential to organize continuous monitoring of patients. The paper exemplifies criteria for assessing the treatment quality in specialized care settings, including primary care. Discussion. It is assumed that the most effective measure to further improve efficacy of COPD treatment is the introduction of remote digital medical devices. A possible integration of the updated standards and quality indicators into digital services will further strengthen the concept of continuous automated remote monitoring of COPD patients. Evidence-based selection and introduction of effective digital solutions into current practice will improve quality of care delivery to patients.

About the authors

D. A. Andreev

Research Institute for Healthcare Organization and Medical Management, 115088, Moscow, Russia

N. N. Kamynina

Research Institute for Healthcare Organization and Medical Management, 115088, Moscow, Russia

References

  1. Hajat C, Stein E. The global burden of multiple chronic conditions: A narrative review // Prev. Med. rep. 2018. Vol. 12. P. 284—293. doi: 10.1016/j.pmedr.2018.10.008
  2. Holtjer J. C.S., Bloemsma L. D., Beijers R. J.H.C.G. et al. Identifying risk factors for COPD and adult-onset asthma: an umbrella review // Eur. Respir. Rev. 2023. Vol. 32, N 168. P. 230009. doi: 10.1183/16000617.0009—2023
  3. André S., Conde B., Fragoso E. et al. COPD and cardiovascular disease // Pulmonology. 2019. Vol. 25, N 3. P. 168—176. doi: 10.1016/j.pulmoe.2018.09.006
  4. Fan H., Wu F., Liu J. et al. Pulmonary tuberculosis as a risk factor for chronic obstructive pulmonary disease: a systematic review and meta-analysis // Ann. Transl. Med. 2021. Vol. 9, N 5. P. 390. doi: 10.21037/atm-20-4576
  5. Qi C., Sun S. W., Xiong X. Z. From COPD to lung cancer: mechanisms linking, diagnosis, treatment, and prognosis // Int. J. Chron. Obstruct. Pulmon. Dis. 2022. Vol. 17. P. 2603—2621. doi: 10.2147/COPD.S380732
  6. Faes K., De Frène V., Cohen J., Annemans L. Resource use and health care costs of COPD patients at the end of life: a systematic review // J. Pain Symptom Manag. 2016. Vol. 52, N 4. P. 588—599. doi: 10.1016/j.jpainsymman.2016.04.007
  7. Dewaele S., Van den Bulck S., Gerne L., Vaes B. Development of primary care quality indicators for chronic obstructive pulmonary disease using a Delphi-derived method // NPJ Prim. Care Respir. Med. 2022. Vol. 32, N 1. P. 12. doi: 10.1038/s41533-022-00276-w
  8. Biewenga J., Kievits R., Romeijnders A. et al. Hoe verloopt de ‘ketenzorg’ voor COPD in Nederland? Evaluatie van de kwaliteitsindicatoren na drie jaar registratie // Huisarts Nu. 2018. Vol. 47. P. 31—35.
  9. Choi G. J., Kang H. The umbrella review: a useful strategy in the rain of evidence // Korean J. Pain. 2022. Vol. 35, N 2. P. 127—128. doi: 10.3344/kjp.2022.35.2.127
  10. GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990—2015: a systematic analysis for the Global Burden of Disease Study 2015 // Lancet Respir. Med. 2017. Vol. 5, N 9. P. 691—706. doi: 10.1016/S2213-2600(17)30293-X
  11. May S. M., Li J. T. C. Burden of chronic obstructive pulmonary disease: healthcare costs and beyond // Allergy Asthma Proc. 2015. Vol. 36, N 1. P. 4—10. doi: 10.2500/aap.2015.36.3812
  12. Hallensleben C., van Luenen S., Rolink E. et al. eHealth for people with COPD in the Netherlands: a scoping review // Int. J. Chron. Obstruct. Pulmon. Dis. 2019. Vol. 14. P. 1681—1690. doi: 10.2147/COPD.S207187
  13. Андреев Д. А., Завьялов А. А. Особенности проведения контроля качества и безопасности медицинской деятельности в онкологии (обзор литературы) // Здравоохранение Российской Федерации. 2021. Т. 65, №5. С. 492—497. doi: 10.47470/0044-197X-2021-65-5-492-497

Statistics

Views

Abstract - 0

PDF (Russian) - 0

Cited-By


PlumX

Dimensions


Copyright (c) 1970 АО "Шико"

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Mailing Address

Address: 105064, Vorontsovo Pole, 12, Moscow

Email: ttcheglova@gmail.com

Phone: +7 903 671-67-12

Principal Contact

Tatyana Sheglova
Head of the editorial office
FSSBI «N.A. Semashko National Research Institute of Public Health»

105064, Vorontsovo Pole st., 12, Moscow


Phone: +7 903 671-67-12
Email: redactor@journal-nriph.ru

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies